ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
PMGC Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.83+0.06 (+2.17%)
Close on Oct 19, 2026
- Market cap
- $13.80M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns PMGC's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| MOA Life Plus Co., Ltd. | 950,000 | 5.03% | 13G (passive) | May 7, 2024 |
| John M. Fife | 91,275 | 9.90% | 13G (passive) amendment | Oct 3, 2025 |
| Streeterville Capital LLC | 90,452 | 9.90% | 13G (passive) | Sep 26, 2025 |
| Bigger Michael | 68,689 | 9.71% | 13G (passive) | Mar 21, 2025 |
| John M Fife | 453,920 | 9.90% | 13G (passive) amendment | May 27, 2026 |
| Braeden Lichti | 450,313 | 7.40% | 13D (active) amendment | Jun 1, 2026 |
| GB Capital Ltd. | 450,287 | 7.40% | 13D (active) | Jun 1, 2026 |
| Graydon Bensler | 3,036,437 | 47.64% | 13D (active) | Mar 26, 2025 |
| Jordan R. Plews | 2,997,287 | 17.00% | 13G (passive) | Jan 31, 2023 |
| JP Bio Consulting LLC | 2,851,454 | 16.50% | 13G (passive) | Jan 31, 2023 |
| Hatem Abou-Sayed | 1,517,738 | 8.70% | 13G (passive) | Jan 31, 2023 |
| Hatem Abou-Sayed MD MBA FACS, a Professional Medical Corporation | 1,371,905 | 7.90% | 13G (passive) | Jan 31, 2023 |
| Santorio Biomedical, LLC | 1,225,000 | 5.90% | 13G (passive) | Aug 15, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Graydon Bensler | Chief Executive Officer, Director | 4,019,557 | 49.65% | Jun 3, 2026 |
| Jeffrey Parry | Director | 3 | 0.00% | Jun 3, 2026 |
| George Kovalyov | Director | 0 | – | Jun 2, 2026 |
| Juliana Daley | Director | 1 | 0.00% | Jun 2, 2026 |
| Lichti Braeden | Director | 3,336,437 | 41.21% | Jun 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Graydon Bensler CEO & CFO, Director, 10% owner | Mar 26, 2025 | Award | +3,036,437 | – | – | 3,036,437 |
| Lichti Braeden Director, 10% owner | Mar 26, 2025 | Award | +3,336,437 | – | – | 3,336,437 |
| Investments Ltd. BWL 10% owner | Dec 28, 2023 | Other | −828,000 | – | – | 1,967,965 |
| Investments Ltd. BWL 10% owner | Dec 28, 2023 | Other | −828,000 | – | – | 2,795,965 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.